Dr. Brantley joined the Vanderbilt Eye Institute in 2010 with a focus on Inherited Retinal Diseases and as Director of the Center for Ocular Pharmacogenomics. He specializes in caring for patients with retinal degenerative diseases such as retinitis pigmentosa, Stargardt macular dystrophy, and age-related macular degeneration. Dr. Brantley’s clinical research program investigates the association between gene variants and disease susceptibility as well how genetics influences response to treatment.
Lab Web Site